Muneyyirci-Delale O

No ORCID on file · 11 papers in corpus
article 2021
F&S reports ·doi:10.1016/j.xfre.2021.05.004

OBJECTIVE: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids. DESIGN…

2020
Obstetrics and gynecology ·doi:10.1097/aog.0000000000003869

ObjectiveTo investigate the safety and efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy for up to 12 months in women with heavy menstrual bleeding associated with uterine leiomyomas.Met…

article 2012
International journal of women's health ·doi:10.2147/ijwh.s27819

PURPOSE: Evaluate the efficacy of norethindrone acetate in the resolution of symptoms and regression of recurrent endometrioma. PATIENTS AND METHODS: Retrospective chart review at SUNY Downstate Medical Center of patients with a history of …

article 2012
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph5101120

The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27-49 years of age presenting with moderate to severe pelvic pain and bleeding. Bleedi…

article 2011
Medical hypotheses ·doi:10.1016/j.mehy.2011.10.008

Lateral cervical displacement has been recognized as a sign of endometriosis; however, other causes of the finding have not been explored. In our experience, patients without endometriosis are presenting with lateral cervical displacement, …

case-report 2008
Complementary therapies in clinical practice ·doi:10.1016/j.ctcp.2008.01.002

BACKGROUND: Phytoestrogens have been thought to have favorable effects on women's health and perhaps in offsetting cancers. The possible adverse effects of phytoestrogens have not been evaluated. CASES: Abnormal uterine bleeding with endom…

other 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.05.002
article 2003
International journal of fertility and women's medicine

OBJECTIVE: To compare the breakthrough bleeding in endometriosis patients treated with Lupron-Depot alone, norethindrone acetate following Lupron-Depot, and norethindrone acetate alone. PATIENTS AND METHODS: 71 women with symptomatic surgic…

article 1999
International journal of fertility and women's medicine

OBJECTIVE: To see whether medical suppressive treatment might be considered in the treatment of a subgroup of patients. with proximal tubal obstruction (PTO), one of the major causes for infertility, often due to endometriosis of the tubout…

article 1998
International journal of fertility and women's medicine

OBJECTIVE: The purpose of the study was to evaluate the efficacy of norethindrone acetate (NA) treatment in 52 women with dysmenorrhea, dyspareunia, noncyclic pelvic pain who had a diagnosis of endometriosis by laparoscopy. RESULTS: Dysmeno…

review 1998
Gynecologic oncology ·doi:10.1006/gyno.1998.4953

We present 4 cases of endometriosis complicated by massive ascites from our institution and a review of 27 cases from the literature. In most of these patients, the presence of ascites with its related symptoms in association with pelvic ma…